Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Dow Rises 80 Points; US Jobless Claims Edge Higher

Published 28/09/2023, 15:16
© Reuters.  Dow Rises 80 Points; US Jobless Claims Edge Higher
UK100
-
STOXX50
-
DE30
-
F40
-
HSCE
-
HSCC
-
BSESITIP
-
BSEPOWER
-
BSEPSU
-
BSETECK
-
BSEBANK
-
FXXPc1
-
SSEC
-
HSH35
-
HSTECH
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded higher this morning, with the Dow Jones gaining around 80 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.24% to 33,630.52 while the NASDAQ rose 0.12% to 13,108.31. The S&P 500 also rose, gaining, 0.25% to 4,285.08.

Check This Out: HP, Roblox And 2 Other Stocks Insiders Are Selling

Leading and Lagging Sectors

Real estate shares rose by 0.9% on Thursday.

In trading on Thursday, utilities shares fell by 0.6%.

Top Headline

U.S. initial jobless claims rose by 2,000 to 204,000 in the week ending Sept. 23, versus market expectations of 215,000.

Equities Trading UP

Bionomics Limited (NASDAQ: BNOX) shares shot up 340% to $4.32 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.

Shares of Baudax Bio, Inc. (NASDAQ: BXRX) got a boost, shooting 93% to $0.5798 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors.

Chico's FAS, Inc. (NYSE: CHS) shares were also up, gaining 62% to $7.47 following the announcement of its acquisition by Sycamore Partners for $1 billion.

Equities Trading DOWN

Ascent Solar Technologies, Inc. (NASDAQ: ASTI) shares dropped 62% to $2.0705 after the company announced pricing of a public offering of units.

Shares of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) were down 52% to $0.19 after the company announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.

Renalytix Plc (NASDAQ: RNLX) was down, falling 31% to $1.36 after the company announced weak FY sales.

Also Check This Out: Top 4 Utilities Stocks You'll Regret Missing This Quarter

Commodities

In commodity news, oil traded down 0.7% to $93.02 while gold traded down 0.1% at $1,890.20.

Silver traded up 0.1% to $22.75 on Thursday while copper rose 1.3% to $3.6820.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 fell 0.1% London’s FTSE 100 fell 0.3% while Spain’s IBEX 35 Index rose 0.6% The German DAX rose 0.1% French CAC 40 rose 0.2%, while Italy’s FTSE MIB Index rose 0.2%.

The industry confidence indicator in the Eurozone improved to -9.0 in September from -9.9 in the prior month, while economic sentiment indicator fell to 93.3 in September from a revised reading of 93.6 a month ago. The consumer confidence indicator was confirmed at -17.8 for September.

Spain's retail trade increased by 7.2% year-over-year for August, while annual inflation rate increased for the third consecutive month to 3.5% in September.

Asia Pacific Markets

Asian markets closed mostly lower on Thursday, with Japan’s Nikkei 225 falling 1.54%, Hong Kong’s Hang Seng Index falling 1.36% and China’s Shanghai Composite Index gaining 0.10%. India’s S&P BSE Sensex, meanwhile, fell 0.9%.

India’s current account deficit shrank to $9.2 billion in the second quarter from $17.9 billion in the year-ago period, while retail sales in Australia rose by 0.2% month-over-month in August.

Economics

U.S. jobless claims rose by 2,000 to 204,000 in the week ending Sept. 23, versus market expectations of 215,000.

The U.S. economy expanded at an annualized rate of 2.1% during the second quarter, unchanged versus the prior estimate, and versus revised 2.2% expansion in the first quarter.

Now Read This: Array Technologies To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Thursday

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,670,700 cases with around 1,176,590 deaths. India confirmed a total of at least 44,998,650 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,871,940 cases of COVID-19 worldwide with more than 6,920,660 deaths.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.